Joint Preservation Therapy Solutions in Roseville, CA

Roseville epidemiology first — then the SKU

CDC PLACES (2023, crude) estimates 9.4% of adults in Roseville have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Obesity 27.2%; arthritis 23.3%. Those three PLACES crude rates (plus Census 147,773) are the local facts on this page. Everything else is the national joint preservation therapy catalog and JE paperwork.

What breaks first: photos, lots, or the LCD

• Adult arthritis here is 23.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 5.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• In a city under 250k, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Roseville street address.
• California is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

City rate, state belt, federal LCD — keep the grains

California shares JE with HI, NV. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 9.4% of adults in Roseville have diagnosed diabetes — 2.6 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.

Do this before you expand SKUs